Mwandishi:
Mhariri:
Imeboreshwa;
ULY CLINIC
ULY CLINIC
27 Oktoba 2026, 13:25:33
Sickle cell disease: stroke and seizures
Sickle cell disease: stroke and seizures
Chanzo: National Sickle Cell Disease Management Guidelines, Ministry of Health Tanzania. Toleo: 2nd edition, June 2026. Mwongozo wa Taifa (supporting guideline).
Stroke in sickle cell disease
Stroke is a common and potentially devastating manifestation of SCD in both children and adults. Previous stroke and high transcranial Doppler ultrasound (TCD) velocities (>200 cm/s) are the major risk factors.
Signs and symptoms
Slurred speech, blurred vision, limp, weakness of one or more limbs.
Abnormal behaviour, sudden personality change.
Severe headache.
Seizures, altered level of consciousness, coma.
Investigations
Random blood glucose; brain CT scan.
Full blood count, HPLC, electrolytes, creatinine, ALT, LDH.
Blood and urine cultures and malaria test if clinically indicated.
Consider lumbar puncture if infection or subarachnoid haemorrhage is possible.
TCD and MRA (magnetic resonance angiography of the brain).
Management of stroke
Ensure the airway is open and give oxygen if indicated.
Place an IV cannula and take blood for investigations.
Give 10% glucose if hypoglycaemic.
If convulsing: diazepam 0.5 mg/kg rectally or 0.15–0.3 mg/kg IV; if convulsions persist for more than 10 minutes, repeat the same dose of diazepam. If convulsions still persist, give a loading dose of phenobarbitone 20 mg/kg IV/IM.
Give IV fluids cautiously at 60% of maintenance because of the risk of cerebral oedema.
If meningitis is suspected: IV ceftriaxone 100 mg/kg once daily.
Give an antimalarial if indicated.
Exchange transfusion within 4 hours of admission to bring haemoglobin S below 30%. If exchange transfusion is not possible, give a top-up blood transfusion (keep Hb around 10 g/dL).
A second exchange transfusion can be considered depending on the neurological status and the HbS level.
Give dexamethasone if there is evidence of raised intracranial pressure (and no cerebral haemorrhage).
In cerebral haemorrhage, consult the neurosurgeons.
Hourly neurological observations (level of consciousness and power).
Start hydroxyurea (see "Sickle cell disease: hydroxyurea therapy").
Provide physiotherapy and occupational therapy.
Seizures and convulsions in sickle cell disease
Children with cerebrovascular disease, for example silent infarcts, are more prone to febrile seizures. Seizures are also common after stroke, subarachnoid haemorrhage or sagittal sinus thrombosis.
Immediate action
Follow the SCD emergency protocol (companion article "Sickle cell disease: emergency assessment and first treatment").
Give an anticonvulsant, usually diazepam (slow IV injection or rectal).
Start antibiotics if the patient is febrile.
Give antipyretics if febrile (paracetamol with or without a non-steroidal anti-inflammatory drug).
Investigations
Random blood glucose.
Full blood picture, urea, HPLC, electrolytes, ALT, calcium, magnesium, LDH, creatinine.
Blood and urine cultures and malaria test if clinically indicated.
Lumbar puncture if clinically indicated (e.g. infection, subarachnoid haemorrhage).
Imaging: electroencephalogram (EEG), CT scan of the brain, MRI/MRA with diffusion imaging, transcranial Doppler (TCD) studies.
Management of seizures
Ensure the airway is open and give oxygen if indicated.
Place an IV cannula and take blood for investigations.
Give 10% glucose if hypoglycaemic.
Diazepam 0.5 mg/kg rectally or 0.15–0.3 mg/kg IV; if convulsions persist for more than 10 minutes, repeat the same dose. If convulsions still persist, give a loading dose of phenobarbitone 20 mg/kg IV/IM.
If meningitis is suspected: IV ceftriaxone 100 mg/kg once daily.
Give an antimalarial if indicated.
Limit rehydration to 60% of maintenance.
In cerebral haemorrhage, consult the neurosurgeons.
Hourly neurological observations (level of consciousness and power).
Start hydroxyurea (see "Sickle cell disease: hydroxyurea therapy").
Notes: if MRI shows ischaemia, MRA shows stenosis or TCD is abnormal, organise exchange transfusion. If the patient fulfils the International League Against Epilepsy (ILAE) definition of epilepsy, treat accordingly (carbamazepine for focal epilepsy, sodium valproate for generalised epilepsy).
Imeandikwa:
27 Oktoba 2026, 13:23:58
Rejea za mada:
1. Ministry of Health Tanzania. National Sickle Cell Disease Management Guidelines, 2nd edition. June 2026. Part II, section 7: Neurological complications (pages 19–21).
